Related Experiment Videos
Biotechnology in pharmaceuticals: the Japanese challenge
Science (New York, N.Y.)
|September 20, 1985
Summary
Biotechnology is revolutionizing pharmaceuticals with new diagnostics and therapeutics. The United States and Japan are key competitors, employing distinct strategies to integrate these advancements into their industries.
Area of Science:
- Biotechnology
- Pharmaceutical Industry
- Drug Development
Background:
- Biotechnology products are increasingly vital for novel diagnostics and therapeutics.
- Significant impact is predicted for the global pharmaceutical sector.
- Biotechnology integration is a key strategic focus for major economies.
Purpose of the Study:
- To examine and compare the strategies of the United States and Japan in adopting biotechnology within their pharmaceutical industries.
- To analyze the competitive landscape shaped by biotechnology advancements.
- To understand the commercialization efforts in biotechnology-driven pharmaceutical development.
Main Methods:
- Comparative analysis of national strategies.
- Review of industry and government initiatives.
- Examination of research and development program integration.
Main Results:
- The United States leverages partnerships with small biotechnology firms for R&D.
- Japan demonstrates strong, coordinated government and industry efforts to expand biotechnology capabilities.
- Competition is intensifying, particularly from Japan's focused commercialization strategies.
Conclusions:
- Both the US and Japan are actively incorporating biotechnology, but with different strategic approaches.
- Japan's concerted efforts pose significant competition to the US in biotechnology commercialization.
- Understanding these diverse strategies is crucial for navigating the evolving pharmaceutical landscape.